Moderna says its vaccine for ages under 6 will be ready for U.S. review in June
Moderna's chief medical officer said the company's vaccine for children under 6 years old will be ready for review by an FDA panel when it meets in June.
Source link
/cloudfront-us-east-2.images.arcpublishing.com/reuters/QACFPFQNABPN5NA6GCH7LZCEHM.jpg "COVID cases break records in Europe, prompting booster shot rethink")